Charles A. Wuertzer, Ph.D.
Affiliations: | 2006 | University of Rochester, Rochester, NY |
Area:
Neuroscience Biology, Animal Physiology BiologyGoogle:
"Charles Wuertzer"Mean distance: 17.71 (cluster 11)
Parents
Sign in to add mentor| Howard J. Federoff | grad student | 2006 | Rochester | |
| (Immuno-therapeutic approaches to prion disease.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Glass C, Wuertzer C, Cui X, et al. (2013) Global Identification of EVI1 Target Genes in Acute Myeloid Leukemia. Plos One. 8: e67134 |
| Wuertzer CA, Sullivan MA, Qiu X, et al. (2008) CNS delivery of vectored prion-specific single-chain antibodies delays disease onset. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 481-6 |
| Maguire-Zeiss KA, Wang CI, Yehling E, et al. (2006) Identification of human alpha-synuclein specific single chain antibodies. Biochemical and Biophysical Research Communications. 349: 1198-205 |
| Tyler CM, Wuertzer CA, Bowers WJ, et al. (2006) HSV amplicons: neuro applications. Current Gene Therapy. 6: 337-50 |
| Wuertzer CA, Sullivan MA, Federoff HJ. (2005) 966. AAV Delivered Single-Chain Antibodies as Passive Immuno-Therapy for Prion Disease Molecular Therapy. 11 |
| Wuertzer CA, Sullivan MA, Federoff HJ. (2004) 552. Single-Chain Antibodies for Viral-Based Passive Immuno-Therapy for Prion Disease: Linear Epitope Mapping and Clearance from Thalamic Injection Molecular Therapy. 9 |
| Richfield EK, Thiruchelvam MJ, Cory-Slechta DA, et al. (2002) Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice. Experimental Neurology. 175: 35-48 |